BamSEC and AlphaSense Join Forces
Learn More

Avenue Therapeutics Inc. – Material Contracts

OTC: ATXI    
Share price (10/7/26): $0.45    
Market cap (10/7/26): $1.479 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 10-Q 4 pages Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because It Is Both (I) Not Material and (II) the Type of Information That the Registrant Treats as Private or Confidential. Patent License Agreement
12/34/56
EX-10.26
from POS AM 71 pages Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because It Is Both (I) Not Material and (II) the Type of Information That the Registrant Treats as Private or Confidential. Stock Purchase Agreement Among Axsome Therapeutics, Inc., Baergic Bio, Inc., and the Stockholders of Baergic Bio, Inc., Including, Without Limitation: Avenue Therapeutics, Inc, for Itself and as Sellers’ Representative; and Children’s Hospital Medical Center, D/B/a Cincinnati Children’s Hospital Medical Center and the Holders of Company Stock Options of Baergic Bio, Inc. Dated as of November 5, 2025
12/34/56
EX-10.1
from 8-K 46 pages Schedule of Exhibits
12/34/56
EX-10.1
from 8-K 3 pages [Form Of] Avenue Therapeutics, Inc. 2015 Incentive Plan Restricted Stock Unit Award Agreement
12/34/56
EX-10.1
from 8-K 1 page Amendment to the Avenue Therapeutics, Inc. 2015 Stock Plan
12/34/56
EX-10.1
from 8-K ~10 pages Holder of Common Stock Purchase Warrants Re: Inducement Offer to Exercise Common Stock Purchase Warrants Dear Holder
12/34/56
EX-10.19
from 10-K 2 pages Consulting Agreement
12/34/56
EX-10.2
from 8-K 8 pages Holder of Common Stock Purchase Warrants Re: Inducement Offer to Exercise Common Stock Purchase Warrants Dear Holder
12/34/56
EX-10.1
from 8-K 8 pages Holder of Common Stock Purchase Warrants Re: Inducement Offer to Exercise Common Stock Purchase Warrants Dear Holder
12/34/56
EX-10.2
from 8-K 38 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 19 pages Placement Agency Agreement October 31, 2023
12/34/56
EX-10.17
from S-1/A 39 pages Securities Purchase Agreement
12/34/56
EX-10.16
from S-1/A 19 pages Placement Agency Agreement , 2023
12/34/56
EX-10.1
from 8-K 2 pages 1111 Kane Concourse, Suite 301, Bay Harbor Islands, Fl 33154 September 8, 2023
12/34/56
EX-10.1
from 8-K 12 pages Avenue Therapeutics, Inc. 2015 Incentive Plan Stock Option Agreement
12/34/56
EX-10.10
from 10-Q 14 pages Registration Rights Agreement
12/34/56
EX-10.9
from 10-Q 75 pages License Agreement by and Between Annji Pharmaceutical Co. Ltd. and Avenue Therapeutics, Inc Dated February 28, 2023
12/34/56
EX-10.1
from 8-K 1 page Amendment to the Avenue Therapeutics, Inc 2015 Incentive Plan
12/34/56
EX-10.7
from 8-K 9 pages Aegis Capital Corp
12/34/56
EX-10.6
from 8-K 5 pages Avenue Therapeutics, Inc. - Lock-Up Agreement January 27, 2023
12/34/56